ebc adjuvant

Info

🌱 來自：clinical pathway-snippets

___(R/L) breast cancer, IDC, s/p ___ (MRM, WE+SLNB, SM+SLNB) on 2023/___/___, pT2(2cm)SLN0(0/3)M0, NG2, LVI, ER/PR/HER2: 8/8/0, FISH: ___,Ki-67 % ___

• ___ Menopause, Premenopause
• Adjuvant chemotherapy:
  • ___ CAF X 6,
  • ___ AC X 4 ⇒ T X 4
• Consult RT
• ___ Letrozole x 5 years, Tamoxifen x 5~10 years or consider LHRH agonist + AI for 5 years
• 2023/___/___: explain purpose of adjuvant treatment is to reduce further risk of local recurrence and distant mets, but not 100%
  • Offer oncotype DX for evaluation but self-paid
  • Arrange #1 CAF/AC on ___/___ (4~5th week), RTC on ___/___ and check lab for prechemotherapy evaluation
  • Olanzepine HS self-paid, akyenzo, dexam, and primperan for emeis.
  • Do cardiac echo if has risk factor: hx of CAD
  • schedule vascular assessment, rehabilitation, nutritional assessment, dental check before chemotherapy